News: Neurocrine Biosciences Inc (NBIX.O)

NBIX.O on Nasdaq

2.19USD
17 Dec 2009
Price Change (% chg)

$-0.08 (-3.52%)
Prev Close
$2.27
Open
$2.26
Day's High
$2.28
Day's Low
$2.16
Volume
219,667
Avg. Vol
153,571
52-wk High
$4.25
52-wk Low
$1.94

view news for:
Select another date:

Wed, Sep 16 2009

HEADLINE STOCKS-Some U.S. stocks on the move on Sept. 16

(Updates to after the open, adds General Mills, KB Home, Warner Music, Fortune Brands, Irwin Financial)

Continue Reading

HEADLINE STOCKS-Some U.S. stocks to watch on Sept. 16

NEW YORK, Sept 16 (Reuters) - Some U.S. stocks to watch on Wednesday:

UPDATE 1-Neurocrine Biosciences gets funding of up to $75 mln

Sept 15 (Reuters) - Neurocrine Biosciences Inc said private investment group Kingsbridge Capital Ltd will provide up to $75 million of capital during the next three years through the purchase of newly issued shares of the biopharmaceutical company.

HEADLINE STOCKS-U.S. stocks on the move on May 6

(Updates to add Amazon, Kenneth Cole, Talbots, True Religion, Parker Drilling, American Capital and SumTotal)

HEADLINE STOCKS-U.S. stocks on the move on May 6

NEW YORK, May 6 (Reuters) - Some U.S. stocks on the move on Wednesday:

HEADLINE STOCKS-U.S. stocks to watch on May 6

NEW YORK, May 6 (Reuters) - Some U.S. stocks to watch on Monday:

Neurocrine Biosciences says CEO to step down

Jan 14 (Reuters) - Neurocrine Biosciences Inc said Chief Executive Officer and President Gary Lyons will step down.

Neurocrine Biosciences sees $7 mln severance charge

Dec 18 (Reuters) - Neurocrine Biosciences Inc said it expects charges of about $7 million during the fourth quarter of 2007 through the first quarter of 2008 related to job cuts at its San Diego unit.

US RESEARCH NEWS-BofA raises Atwood Oceanics to buy

Following are the research actions reported by Reuters on Monday For research actions reported earlier in the day, please double click on [nBNG331084] [nBNG102815] For a snapshot of research actions, please double click on [SNAP/RCH] --------------------------------------------------------------- ------------ STOCK RESEARCH BY ACTION Atwood Oceanics Banc of America Raises to buy from neutral --------------------------------------------------

US RESEARCH NEWS-UBS cuts Neurocrine Biosciences price target

Following are the research actions reported by Reuters on Friday as of 0914 ET For actions reported earlier in the day, please double click [nBNG82868] --------------------------------------------------------------- ------------ STOCK RESEARCH BY ACTION Neurocrine Biosciences UBS Cuts price target to $6 from $11; keeps neutral rating --------------------------------------------------------------- -------

Select another date:

Market Views

» More NBIX.O Market Views

Press Releases

view news for: